Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to ...

Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...

Simone Cristicchi cancels the concert scheduled for July 12 at Forte di Bard in Valle d'Aosta: "It is with great regret that ...

Simone Cristicchi cancels the concert scheduled for July 12 at Forte di Bard in Valle d'Aosta: "It is with great regret that ...

Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and ...

Meningitis can be a frightening diagnosis. Our expert guide breaks down the different types—bacterial, viral, and fungal—and ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world's population and is generally ...

Scientists are modifying the herpes simplex virus 1 (HSV-1) to create a promising new treatment for late-stage, treatment-resistant skin cancer.